The Journal of mHealth Vol 1 Issue 3 (June 2014) - Page 46

Lab Quality Testing in the Palm of Your Hand Continued from page 43 to in vitro diagnostic is poised to increase from 13% to 17% over the next five years, leading to a market of around $30B in 2019. The application of these types of portable mobile testing devices covers a range of scenarios, including: Emergency testing; Home tests; Doctor’s office screening; Decentralised hospital tests; Environmental testing; Forensic and military; Thirdworld infections; and, Agro-food. Medical Device applications in microfluidics are being enhanced by electric field manipulation, novel ligand sequestration, photometrics, spectroscopy, florescence, and a whole host of adjunct technologies. The potential applications in the medical space are nearly limitless and with advancements in micro fabrication, have become very cost effective. There are several advantages to the lab-on-a-chip approach, beyond the convenience of being able to test in the field. The test sample required is much smaller because of the sensitivity of the chip, which is useful if you need to measur e the very earliest stages of a disease when the chemical markers in the blood are low in number and would probably be missed by standard tests. New Financing Options Driving Development Another interesting factor driving forward the adoption of some of these types of testing device, (particularly consumer targeted products) are the use of crowd-funded financing options to help develop devices specific to certain disease types. Crowd-funding investment platforms, allow developers and innovative start-ups to go directly to their end consumer (patients) prior to fully developing a device. By gaining support and financial backing, often through pre-orders, companies reduce their risk of going to market, by ensuring that at the very least prototyping funds can be secured. The initial sales of the product can help deliver information on efficacy and the capabilities of a solution, which can in turn assist in gaining additional market approval. By undertaking this type of route to market companies are also creating communities of potential users, that have a vested interest in the successful development of the product. This significantly helps to gain traction in the marketplace, test products, secure early sales, and demonstrate a demand that can then be used as evidence to secure further future development funding from more traditional financing sources, and help ensure the long-term viability of the solution. 1. 2. Dubois, J A., 2013. "The Role of Point-of-Care-Testing and Rapid Testing." Medical Laboratory Observer Yole Developpment Report 2014. “Point of Care Testing 2014: Applications for Microfluidic Technologies.” n How healthy is your workforce? dacadoo measures the health and wellbeing of your workforce in real-time. www.dacadoo.com 44 June 2014 Want to learn about the benefits of Field Testing for Health apps & systems? Visit www.pass.ch/fieldtesting